Regentis Biomaterials (RGNT) Share-based Compensation (2024 - 2025)
Regentis Biomaterials' (RGNT) quarterly Share-based Compensation came in at $965000.0 in Q4 2025, up 1117.05% year-over-year from $79290.0 in Q4 2024, and up 1117.05% quarter-over-quarter from $79290.0 in Q4 2024.
Powered by 
Analysis
Regentis Biomaterials (RGNT) Share-based Compensation (2024 - 2025) Analysis & Trends
Regentis Biomaterials (RGNT) has reported Share-based Compensation for 2 consecutive years, with $965000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Share-based Compensation rose 1117.05% year-over-year to $965000.0 in Q4 2025; TTM through Dec 2025 was $965000.0, a 1117.05% increase from a year earlier, with the FY2025 full-year figure at $7.0 million, up 8781.32% from the prior year.
- Share-based Compensation was $965000.0 for Q4 2025 at Regentis Biomaterials, up from $79290.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $965000.0 in Q4 2025 and troughed at $79290.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Regentis Biomaterials | 1.12 Mn | -6.26 Mn | - | 965,000.00 |